Developer and manufacturer of injection and infusion systems Ypsomed announced as Insulin Safety Week 2024 sponsor – supporting efforts to reduce errors within the profession. Created to raise awarene...
A diabetic foot screening workshop is being held this month, offering all those involved in diabetic foot checks the opportunity to learn new skills or refresh their existing knowledge. The event, on ...
Toe ulceration, elevated C-reactive protein, and the presence of osteomyelitis were associated with the surgical management of complicated diabetic foot disease, new research has identified. While sur...
A qualitative study which explored the patient experiences of free tissue transfer for reconstruction of diabetic foot disease has reported it can be “positively life-changing” for those affected. Wit...
Research into the outcomes for people admitted with diabetic foot ulcer to hospitals which serve an ethnically diverse population has revealed the high amputation risk – 44 per cent – among its mostly...
Leading supplier of innovative diabetes management solutions GlucoRx announced as Insulin Safety Week 2024 sponsor – supporting efforts to reduce errors within the profession. Created to raise awarene...
As part of the buildup to Insulin Safety Week 2024, a recent webinar proved a resounding success, attracting healthcare professionals from across the UK and Ireland to increase their understanding of ...
Leading global healthcare company Sanofi Healthcare announced as Insulin Safety Week 2024 sponsor – supporting efforts to reduce errors within the profession. Created to raise awareness of insulin saf...
A webinar which explored how Artificial Intelligence can help treat and manage diabetic foot ulcers is now available to view. Chaired by Professor Paul Chadwick, Executive Vice President of SpectralMD...